Skip to main content
Novateor Research Laboratories Limited logo

Novateor Research Laboratories Limited — Investor Relations & Filings

Ticker · 542771 ISIN · INE08JY01013 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-30 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 542771

About Novateor Research Laboratories Limited

https://novateor.com/

Novateor Research Laboratories Limited is a research-driven healthcare company specializing in the development and manufacturing of innovative oral care and pharmaceutical products. The company focuses on creating advanced solutions for dental hygiene and personal care, most notably through its flagship brand, Smyle. Its product portfolio includes teeth whitening kits, specialized toothpastes, and other oral hygiene formulations designed to meet evolving consumer needs. Novateor emphasizes research and development to ensure high-quality, effective healthcare solutions. The company operates with a commitment to scientific excellence, leveraging modern laboratory facilities to innovate within the personal care and wellness sectors. Its core activities encompass the entire lifecycle of product development, from initial research and formulation to manufacturing and distribution of specialized healthcare items.

Recent filings

Filing Released Lang Actions
Approval and adoption of audited Financial Results for the half year and year ended on March 31, 2026
Interim / Quarterly Report Classification · 85% confidence The document is a board meeting outcome filed under SEBI LODR regulations, primarily attaching audited standalone financial results for the half-year and year ended March 31, 2026, including a detailed audit report, statement of assets and liabilities, cash flow statements, and audit opinion. It contains substantive financial statements and audit disclosures rather than a short earnings summary or merely an announcement. It is therefore a comprehensive regulatory financial report for a period shorter than (and including) the full fiscal year but distinct from a full Annual Report, fitting the Interim / Quarterly Report category. FY 2026
2026-05-30 English
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the audited ....
Regulatory Filings Classification · 90% confidence The document is a notice of a scheduled Board of Directors meeting sent to the stock exchange under SEBI LODR Regulation 29. It does not contain financial results or a report itself, nor does it announce changes in directors, dividends, mergers, or similar actions. It is a routine regulatory announcement (board meeting intimation), which falls under the general Regulatory Filings category (RNS).
2026-05-26 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.